Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Endocrinology

• Publication date

  1985-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO-117-4-1409PMID 4029083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.

  1984cited by this paper
• Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.

  1984cited by this paper
• Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.

  1984cited by this paper
• Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line.

  1984cited by this paper
• Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.

  1984cited by this paper
• Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.

  1984cited by this paper
• Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene.

  1984cited by this paper
• Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7.

  1983cited by this paper
• Antiestrogenic effects of LY 117018 in MCF-7 cells.

  1983cited by this paper
• Physicochemical and genetic evidence for specific antiestrogen binding sites.

  1983cited by this paper
• Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture.

  1982cited by this paper
• Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

  1982cited by this paper
• Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma.

  1981cited by this paper
• Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.

  1981cited by this paper
• Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.

  1981cited by this paper
• Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7

  1981cited by this paper
• Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.

  1981cited by this paper
• The problem of nonresponding estrogen receptor‐positive patients with advanced breast cancer

  1980cited by this paper
• A secreted glycoprotein induced by estrogen in human breast cancer cell lines.

  1980cited by this paper
• Monoclonal antibodies to human estrogen receptor.

  1980cited by this paper
• Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.

  1980cited by this paper
• Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer

  1980cited by this paper
• Assay for nanogram quantities of DNA in cellular homogenates.

  1979cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper
• Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.

  1978cited by this paper
• A simple computer program for quantitation and Scatchard analysis of steroid receptor proteins.

  1977cited by this paper
• Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines.

  1977cited by this paper
• REGULATION OF PROGESTERONE RECEPTOR FORMATION BY ESTROGEN ACTION *

  1977cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Oestrogen-responsive human breast cancer in long term tissue culture

  1975cited by this paper
• Receptors from glucocorticoid-sensitive lymphoma cells and two clases of insensitive clones: physical and DNA-binding properties.

  1974cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper
• Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.

  1973cited by this paper
• Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells.

  1972cited by this paper
• Polypeptides of the tail fibres of bacteriophage T4.

  1971cited by this paper
• The results of adrenalectomy in advanced breast cancer in 500 consecutive patients.

  1967cited by this paper

• Modelling anti-estrogen resistance in estrogen receptor-positive breast cancer: molecular mechanisms and emerging therapeutic strategies

  2025cites this paper
• Targeting METTL3 Induces a Metabolic Vulnerability in ER+ Breast Carcinoma Cells.

  2025cites this paper
• Cell facilitation promotes growth and survival under drug pressure in breast cancer

  2023cites this paper
• Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development

  2022cites this paper
• An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer

  2022cites this paper
• Ecological interactions in breast cancer: Cell facilitation promotes growth and survival under drug pressure

  2021cites this paper
• HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

  2021cites this paper
• Serine synthesis influences tamoxifen response in ER+ human breast carcinoma.

  2020cites this paper
• ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis

  2020cites this paper
• Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer

  2018cites this paper
• Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer

  2018cites this paper
• Ancestral Dependence on Breast Stemness and Nucleotide Excision Repair in Breast Cancer Stem Cells in Novel Human Model Systems

  2018cites this paper
• Estrogen Receptor Regulation of MicroRNAs in Breast Cancer

  2018cites this paper
• BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells

  2017cites this paper
• S100β as a serum marker in endocrine resistant breast cancer

  2017cites this paper
• Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

  2017cites this paper
• Role of MIR-29B-1 and MIR-29A in endocrine-resistant breast cancer.

  2017cites this paper
• BRCA 1-Mimetic Compound NSC 35446 . Hcl Inhibits IKKB Expression by Reducing Estrogen Receptor-Occupancy in the IKKB Promoter and Inhibits NF-B Activity in Antiestrogen-Resistant Human Breast Cancer Cells

  2017cites this paper
• Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells

  2016cites this paper
• Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors

  2016cites this paper
• GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells

  2016cites this paper
• miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets

  2015cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Copyedited and fully formatted PDF and full text (HTML) versions will be made available soon.

  2014cites this paper
• NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer

  2014cites this paper
• VAV3 mediates resistance to breast cancer endocrine therapy

  2014cites this paper
• β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression

  2014influential citation
• Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.

  2014cites this paper
• Molecular Modulation of Estrogen-Induced Apoptosis in Long-Term Estrogen-Deprived Breast Cancer Cells

  2014cites this paper
• Acquired Resistance to Tamoxifen: Back to the Beginning

  2013cites this paper
• Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells

  2013influential citation
• Models and mechanisms of acquired antihormone resistance in breast cancer: significant clinical progress despite limitations

  2012influential citation
• Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.

  2012cites this paper
• Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

  2011cites this paper
• Interaction of Developmental Transcription Factor HOX11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer

  2010cites this paper
• Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

  2010cites this paper
• Effects of LY117018 (a SERM analog of raloxifene) on tumor suppressor proteins and proliferation of breast cancer cells

  2010cites this paper
• IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis

  2010influential citation
• Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.

  2010cites this paper
• BCL-2 family function in antiestrogen-resistant breast cancer cells

  2009cites this paper
• Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence

  2009cites this paper
• Roles of the Estrogen Receptors and the Nuclear Matrix in Breast Cancer Development and Tamoxifen Resistance

  2009cites this paper
• Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer

  2008influential citation
• Acquisition of Hormone-independent Growth in MCF-7 Cells Is Accompanied by Increased Expression of Estrogen-regulated Genes but Without Detectable DNA Amplifications

  2007cites this paper
• Molecular Mechanism of Nucleotide Excision Repair Deficiency in Novel Breast Cancer Cell Lines

  2006cites this paper
• Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.

  2006cites this paper
• Binding Site Activity Estrogen : Possible Mediation by Excessive Antiestrogen Resistance to Tamoxifen with Persisting Sensitivity to Updated Version

  2006cites this paper
• Advances in Brief MCF 7 / LCC 2 : A 4-Hydroxytamoxifen Resistant Human Breast Cancer Variant That Retains Sensitivity to the Steroidal Antiestrogen ICI 182 , 78 o 1

  2006cites this paper
• Cancer T47D Cells by Immunocytochemistry

  2005cites this paper
• Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668

  2005cites this paper
• Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

  2005cites this paper
• Drug resistance to tamoxifen during breast cancer therapy

  2004cites this paper
• Antiestrogen resistance in ER positive breast cancer cells

  2004cites this paper
• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

  2003cites this paper
• Insights into the Molecular Mechanism of SERMs Through New Laboratory Models

  2002cites this paper
• Cellular and molecular pharmacology of antiestrogen action and resistance.

  2001cites this paper
• Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells*

  2001cites this paper
• Increased expression of cytochrome p450 1A1 and 1B1 genes in anti‐estrogen–resistant human breast cancer cell lines

  2000cites this paper
• Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines.

  1999cites this paper
• Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050)

  1998cites this paper
• A Pure Antiestrogen, ICI 182,780, Stimulates the Growth of Tamoxifen-Resistant KPL-1 Human Breast Cancer Cells in vivo but not in vitro

  1998cites this paper
• Clomiphene analogs with activity in vitro and in vivo against human breast cancer cells.

  1998cites this paper
• Increased Sensitivity of the Antiestrogen‐Resistant MCF‐7/LY2 Human Breast Carcinoma Cell Line to Apoptosis Induced by the Novel Microtubule Stabilizing Agent (+)‐Discodermolide

  1998cites this paper
• The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.

  1998cites this paper
• Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.

  1997cites this paper
• Steroid hormones and cancer: (II) Lessons from experimental systems.

  1997cites this paper
• MCF-7: the first hormone-responsive breast cancer cell line.

  1997cites this paper
• Resistance of human breast‐cancer cells to the pure steroidal anti‐estrogen ICI 182,780 is not associated with a general loss of estrogen‐receptor expression or lack of estrogen responsiveness

  1997cites this paper
• Steroid hormones and cancer: (II) lessons from experimental system

  1997cites this paper
• Antiestrogen Resistance in Human Breast Cancer

  1997cites this paper
• Pure Antiestrogens The Most Important Advance in the Endocrine Therapy of Breast Cancer since 1896? a

  1996cites this paper
• Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.

  1996cites this paper
• Role of TGF beta in the anti-estrogen response/resistance of human breast cancer.

  1996cites this paper
• Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.

  1996cites this paper
• Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro.

  1996cites this paper
• Role of TGFβ in the anti-estrogen response/resistance of human breast cancer

  1996cites this paper
• Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.

  1996cites this paper
• Regulation and role of TGF beta production in breast cancer.

  1996cites this paper
• Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.

  1996cites this paper
• Properties and mode of action of pure antioestrogens in breast cancer in vitro

  1996cites this paper
• Regulation and Role of TGFβ Production in Breast Cancer a

  1996cites this paper
• Direct selection of expressed sequences within a 1-Mb region flanking BRCA1 on human chromosome 17q21.

  1995cites this paper
• Human breast cancer cell lines resistant to pure anti‐estrogens are sensitive to tamoxifen treatment

  1995cites this paper
• Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen:31P NMR studies

  1995influential citation
• Responses to Pure Antiestrogens (ICI 164384, ICI182780) in Estrogen‐Sensitive and‐Resistant Experimental and Clinical Breast Cancer a

  1995cites this paper
• Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone.

  1994cites this paper
• Drug Resistance to Antioestrogen Therapy

  1994cites this paper
• Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.

  1994cites this paper
• Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.

  1994cites this paper
• A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture.

  1994cites this paper
• Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

  1993cites this paper
• Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.

  1993cites this paper
• Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?

  1993cites this paper
• Tamoxifen resistance in breast cancer.

  1993cites this paper
• MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

  1993cites this paper
• Molecular mechanisms of resistance to tamoxifen therapy in breast cancer.

  1993cites this paper
• Hormone resistance, invasiveness, and metastatic potential in breast cancer

  1993cites this paper
• cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.

  1993cites this paper
• William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.

  1993cites this paper
• The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.

  1992cites this paper
• An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.

  1992cites this paper